Pharmaceutical Tech looks at the GLP-1 future

“The GLP-1 drug shortage is over. What’s next for the compounders?” asks Pharmaceutical Technology magazine. APC’s Scott Brunner was one of the experts it turned to for a peek at the potential future, as well as some of the nuance in the current marketplace.

Related posts

Glutathione can literally be a life-saver for firefighters, but, as LA's NBC station explains, "the...

In "Zepbound copycats remain online despite FDA ban," it looks at ways some compounders are...

You’ve probably seen the news that Eli Lilly will begin selling Zepbound in vials by mail. What you...